Program

2:00 – 2:15p.m.	OPENING SESSION – Robson Santos, Brazil
2:15 – 2:45 p.m.	Rhian Touyz, Canada – The vascular proteome in hypertension
2:45 – 3:15 p.m.	Robert Widdop, Australia – AT2R stimulation in human lungs
3:15 – 3:45p.m.	Robson Santos, Brazil – Alamandine-(1-5): a new kid on the block?
3:45 – 4:15p.m.	COFFEE BREAK
SESSION II	Carlos Sánchez Ferrer, Dulce Elena Casarini and Rhian Touyz
4:15 – 4:45 p.m.	Minolfa Prieto, USA – The PRR and prorenin: a dynamic duet in inflammation
4:45 – 5:15 p.m.	Maria de Fátima Leite, Brazil – Steatosis and fibrosis Walk into a Bar… Angiotensins. Kick Them Out
5:15 – 5:45 p.m.	Tracey Gaspari, Australia – Targeting the AT4R/IRAP in diabetes-induced cardiovascular disease
5:45 – 6:15 p.m.	Mark Chappell, USA – Predictive Value of Extensive Profiling of the Renin-Angiotensin System in Critical Illness (via Zoom)
6:15 – 8:00 p.m.	POSTER SESSION – Maria José Campagnole, Silvia Guatimosim and Andrea Haibara

MONDAY – 07/21/2025

SESSION III – Daniel Vilela, Friederike Klempin and Tracey Gaspari

8:00 – 8:30 a.m.	Pablo Nakagawa, USA – Advances in autonomic modulation by the brain renin-angiotensin system
8:30 – 9:00 a.m.	Augusto Montezano, Canada – From Spike to Dysfunction: Unraveling ACE2-Dependent Mechanisms of Vascular Injury in SARS-CoV-2
9:00 – 9:30 a.m.	Jan Danser, Netherlands – Very long-term blockade of the renin-angiotensin system: risks and benefits
09:30 – 10:00 a.m.	Annet Kirabo, USA – Immune Cell Renin Angiotensin System in Salt-Sensitive Hypertension
10:00 – 10:30 a.m.	COFFEE BREAK
SESSION IV	Ana Cristina Simões e Silva, Igor Maciel and Mark Chappell
10:30 – 11:00 a.m.	Eliete Dalla Corte Frantz, Brazil – Adipose tissue plasticity mediated by the counter regulatory axis
11:00 – 11:30 a.m.	Colin Sumners, USA – Angiotensin AT2 receptor-mediated actions in the brain: uppin the Anti
11:30 – 12:00 p.m.	Michael Bader, Germany – Carboxypeptidase M, a novel target for hypertensive and ischemic kidney disease
12:00 – 2:00 p.m.	LUNCH

SESSION V – Carlos Castro, Maria Cláudia Irigoyen and Mariela Gironacci

2:00 – 2:30 p.m.	Edward Sturrock, South Africa – The effect of carbamylation on ACE1 activity and RAS peptide processing: Implications for patients with chronic kidney disease
2:30 – 3:00 p.m.	Marko Poglitsch, Austria – Angiotensin based biomarkers for clinical management of uncontrolled hypertension
3:00 – 3:30 p.m.	Concepción Peiró, Spain – Angiotensin-(1-7) and Alamandine: novel tools for senotherapeutics?
3:30 – 4:00 p.m.	COFFEE BREAK

SESSION VI – Daniella Bonaventura, Patrícia Brum and Concepción Peiró

4:00 – 4:30 p.m.	Eric Lazartigues, USA – Targeting miRNA within the RAS for cardiometabolic diseases
4:30 – 5:00 p.m.	Natalia Alenina, Germany – ACE2, serotonin, and metabolic regulation
5:00 – 5:30 p.m.	Catherine Llorens-Cortès, France – Advancing heart failure treatment with metabolically stable apelin analogs
5:30 – 6:00 p.m.	Ulrike Steckelings, Denmark – The ongoing characterisation of angiotensin-(1-5), a new hormone within the RAAS
6:00 – 7:30 p.m.	POSTER SESSION – Ulrike Steckelings, Natalia Alenina and Anne Monique
7:30 – 9:00 p.m.	DINNER

TUESDAY – 07/22/2025

SESSION VII – Edilamar Menezes, Ronaldo de Carvalho Araújo and Michael Bader

8:00 – 8:30 a.m.	João Bosco Pesquero, Brazil – Genetic features of bradykinin-forming cascade and vascular endothelium permeability regulation pathways in Brazil families with recurrent angioedema
8:30 – 9:00 a.m.	Frederic Frezard, Brazil – Liposomal Angiotensin-(1-7): Therapeutic Potential by Non-Invasive Routes
9:00 – 9:30 a.m.	Mariela Gironacci, Argentina – Unveiling the Nuclear Translocation of the Mas Receptor in Hypertensive Rat Neurons
9:30 – 10:00 a.m.	COFFEE BREAK

SESSION VIII – Katia De Angelis, Maria Luiza Barreto Chaves and Lenice Becker

10:00 – 10:30 a.m.	Anne Monique Nuyt, Canada – Developmental origins of cardiovascular diseases after preterm birth: from bench to bedside and back
10:30 – 11:00 a.m.	Diogo Perucheti, Brazil – Crosstalk Between Renin-Angiotensin System Peptides in the Pathogenesis of Diabetic Kidney Disease
11:00 – 11:30 a.m.	Manuela Morato, Portugal – Angiotensin-converting enzymes in the feces: what do we know by now
11:30 – 12:00 p.m.	Yagna Jarajapu, USA – Alamandine/MrgD Pathway and Gut-Bone Marrow Axis in Aging (via Zoom)
12:00 p.m.	AWARDS SESSION AND CLOSING CEREMONY – Robson Santos and Maria José Campagnole